Benedetta Kassabian,Amanda M Levy,Elena Gardella,Angel Aledo-Serrano,Amitha L Ananth,Alejandro J Brea-Fernández,Roseline Caumes,Nicolas Chatron,Alice Dainelli,Matthias De Wachter,Anne-Sophie Denommé-Pichon,Thomas J Dye,Elisa Fazzi,Roxanne Felt,Alberto Fernández-Jaén,Montse Fernández-Prieto,Emily Gantz,Piotr Gasperowicz,Antonio Gil-Nagel,David Gómez-Andrés,Hansel M Greiner,Renzo Guerrini,Maria K Haanpää,Minttu Helin,Juliane Hoyer,Anna C E Hurst,Staci Kallish,Shefali N Karkare,Amjad Khan,Lotte Kleinendorst,Johannes Koch,Sanjeev V Kothare,Suzanna M Koudijs,Lieven Lagae,Phillis Lakeman,Kathleen A Leppig,Gaetan Lesca,Diego Lopergolo,Laina Lusk,Alex Mackenzie,Davide Mei,Rikke S Møller,Elaine M Pereira,Konrad Platzer,Chloe Quelin,Anya Revah-Politi,Sylvain Rheims,Agustí Rodríguez-Palmero,Andrea Rossi,Filippo Santorelli,Syndi Seinfeld,Erick Sell,Donna Stephenson,Krzysztof Szczaluba,Eugen Trinka,Muhammad Umair,Hilde Van Esch,Mieke M van Haelst,Danielle C M Veenma,Sacha Weber,Sarah Weckhuysen,Pia Zacher,Zeynep Tümer,Guido Rubboli

Abstract:Objective: The postsynaptic density protein of excitatory neurons PSD-95 is encoded by discs large MAGUK scaffold protein 4 (DLG4), de novo pathogenic variants of which lead to DLG4-related synaptopathy. The major clinical features are developmental delay, intellectual disability (ID), hypotonia, sleep disturbances, movement disorders, and epilepsy. Even though epilepsy is present in 50% of the individuals, it has not been investigated in detail. We describe here the phenotypic spectrum of epilepsy and associated comorbidities in patients with DLG4-related synaptopathy. Methods: We included 35 individuals with a DLG4 variant and epilepsy as part of a multicenter study. The DLG4 variants were detected by the referring laboratories. The degree of ID, hypotonia, developmental delay, and motor disturbances were evaluated by the referring clinician. Data on awake and sleep electroencephalography (EEG) and/or video-polygraphy and brain magnetic resonance imaging were collected. Antiseizure medication response was retrospectively assessed by the referring clinician. Results: A large variety of seizure types was reported, although focal seizures were the most common. Encephalopathy related to status epilepticus during slow-wave sleep (ESES)/developmental epileptic encephalopathy with spike-wave activation during sleep (DEE-SWAS) was diagnosed in >25% of the individuals. All but one individual presented with neurodevelopmental delay. Regression in verbal and/or motor domains was observed in all individuals who suffered from ESES/DEE-SWAS, as well as some who did not. We could not identify a clear genotype-phenotype relationship even between individuals with the same DLG4 variants. Significance: Our study shows that a subgroup of individuals with DLG4-related synaptopathy have DEE, and approximately one fourth of them have ESES/DEE-SWAS. Our study confirms DEE as part of the DLG4-related phenotypic spectrum. Occurrence of ESES/DEE-SWAS in DLG4-related synaptopathy requires proper investigation with sleep EEG.

De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy

De novo variants in neurodevelopmental disorders with epilepsy

Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy

De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias (vol 103, Pg 666, 2018)

De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy

Case report: Novel variants cause developmental and epileptic encephalopathy in three unrelated families from Mali

Loss of symmetric cell division of apical neural progenitors drives -related developmental and epileptic encephalopathy

Developmental epileptic encephalopathy in DLG4-related synaptopathy

De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome

De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity

Case Report: Causative De Novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features

Unraveling neuroimaging insights in developmental epileptic encephalopathy type 25: a comprehensive review of reported cases and a novel SLC13A5 variant

Bi-allelic SNAPC4 variants dysregulate global alternative splicing and lead to neuroregression and progressive spastic paraparesis

De novo variants in GABRA4 are associated with a neurological phenotype including developmental delay, behavioral abnormalities and epilepsy

De Novo Variants in MAPK8IP3 Cause Intellectual Disability with Variable Brain Anomalies

De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEP.

De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures

Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy

The neuroimaging spectrum of SLC13A5 related developmental and epileptic encephalopathy

A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.